Fulcrum Therapeutics
FULC
#8396
Rank
HK$2.20 B
Marketcap
HK$28.92
Share price
-0.54%
Change (1 day)
-67.08%
Change (1 year)

EPS for Fulcrum Therapeutics (FULC)

EPS in 2026 (TTM): -HK$9.45

According to Fulcrum Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$9.48. In 2025 the company made an earnings per share (EPS) of -HK$9.25 a decrease over its 2024 EPS that were of -HK$1.57.

EPS history for Fulcrum Therapeutics from 2019 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$9.452.17%
2025-HK$9.25490%
2024-HK$1.57-87.34%
2023-HK$12.38-36.29%
2022-HK$19.448.3%
2021-HK$17.95-18.51%
2020-HK$22.03-31.36%
2019-HK$32.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-HK$10.58 11.57%๐Ÿ‡บ๐Ÿ‡ธ USA